Brad serves as an advisor to the firm’s management and investment committee in developing strategy and evaluation of investment opportunities. As a special advisor, he also has a particular focus on evaluating new investment opportunities in the healthcare industry.
Dr. Hirsch is Senior Medical Director for Flatiron Health and a practicing medical oncologist with Texas Oncology in Dallas. At Flatiron Health, he helps to lead multiple efforts including value based care initiatives, collaborations with life sciences companies, and the development of novel research capabilities. Prior to joining Flatiron, he served as Medical Director of Informatics and Health Economics and Outcomes Research (HEOR) for US Oncology and was as an Assistant Professor at Duke University in the Duke Cancer Institute and Duke Clinical Research Institute. He is also a Co-Founder and Board Member at SignalPath Research, a start up leveraging technology to make clinical trials more efficient and effective. Across these roles, he focuses on the economic and organizational complexities of health care delivery and on the use of information systems to improve cancer care and patient engagement.
Board Memberships (Current and Past)
SignalPath Research, current
Boys and Girls Club of Dallas, past
St. Mark’s School of Texas – Alumni, past
M.B.A., with concentration in Health Sector Management, Fuqua School at Duke University
M.D., UT Southwestern Medical School
B.A. in Economics and the Biological Basis of Behavior, University of Pennsylvania